134 related articles for article (PubMed ID: 30274306)
21. Doxorubicin-loaded magnetic nanoparticle clusters for chemo-photothermal treatment of the prostate cancer cell line PC3.
Zhang W; Zheng X; Shen S; Wang X
Biochem Biophys Res Commun; 2015 Oct; 466(2):278-82. PubMed ID: 26362176
[TBL] [Abstract][Full Text] [Related]
22. Aurora B kinase is a potent and selective target in MYCN-driven neuroblastoma.
Bogen D; Wei JS; Azorsa DO; Ormanoglu P; Buehler E; Guha R; Keller JM; Mathews Griner LA; Ferrer M; Song YK; Liao H; Mendoza A; Gryder BE; Sindri S; He J; Wen X; Zhang S; Shern JF; Yohe ME; Taschner-Mandl S; Shohet JM; Thomas CJ; Martin SE; Ambros PF; Khan J
Oncotarget; 2015 Nov; 6(34):35247-62. PubMed ID: 26497213
[TBL] [Abstract][Full Text] [Related]
23. A dual factor activated metal-organic framework hybrid nanoplatform for photoacoustic imaging and synergetic photo-chemotherapy.
Zhu W; Chen M; Liu Y; Tian Y; Song Z; Song G; Zhang X
Nanoscale; 2019 Nov; 11(43):20630-20637. PubMed ID: 31641722
[TBL] [Abstract][Full Text] [Related]
24. In Vivo Deep Tissue Fluorescence and Magnetic Imaging Employing Hybrid Nanostructures.
Ortgies DH; de la Cueva L; Del Rosal B; Sanz-Rodríguez F; Fernández N; Iglesias-de la Cruz MC; Salas G; Cabrera D; Teran FJ; Jaque D; Martín Rodríguez E
ACS Appl Mater Interfaces; 2016 Jan; 8(2):1406-14. PubMed ID: 26713893
[TBL] [Abstract][Full Text] [Related]
25. Reversing cold tumors to hot: An immunoadjuvant-functionalized metal-organic framework for multimodal imaging-guided synergistic photo-immunotherapy.
Fan Z; Liu H; Xue Y; Lin J; Fu Y; Xia Z; Pan D; Zhang J; Qiao K; Zhang Z; Liao Y
Bioact Mater; 2021 Feb; 6(2):312-325. PubMed ID: 32954050
[TBL] [Abstract][Full Text] [Related]
26. Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas.
Westermann F; Muth D; Benner A; Bauer T; Henrich KO; Oberthuer A; Brors B; Beissbarth T; Vandesompele J; Pattyn F; Hero B; König R; Fischer M; Schwab M
Genome Biol; 2008 Oct; 9(10):R150. PubMed ID: 18851746
[TBL] [Abstract][Full Text] [Related]
27. Mutations in PIK3CA are infrequent in neuroblastoma.
Dam V; Morgan BT; Mazanek P; Hogarty MD
BMC Cancer; 2006 Jul; 6():177. PubMed ID: 16822308
[TBL] [Abstract][Full Text] [Related]
28. Clastogenicity, photo-clastogenicity or pseudo-photo-clastogenicity: Genotoxic effects of zinc oxide in the dark, in pre-irradiated or simultaneously irradiated Chinese hamster ovary cells.
Dufour EK; Kumaravel T; Nohynek GJ; Kirkland D; Toutain H
Mutat Res; 2006 Sep; 607(2):215-24. PubMed ID: 16797222
[TBL] [Abstract][Full Text] [Related]
29. Targeting the Difficult-to-Drug CD71 and MYCN with Gambogic Acid and Vorinostat in a Class of Neuroblastomas.
Bishayee K; Habib K; Sadra A; Huh SO
Cell Physiol Biochem; 2019; 53(1):258-280. PubMed ID: 31313541
[TBL] [Abstract][Full Text] [Related]
30. Enhanced Radiosensitization of Gold Nanospikes via Hyperthermia in Combined Cancer Radiation and Photothermal Therapy.
Ma N; Jiang YW; Zhang X; Wu H; Myers JN; Liu P; Jin H; Gu N; He N; Wu FG; Chen Z
ACS Appl Mater Interfaces; 2016 Oct; 8(42):28480-28494. PubMed ID: 27689441
[TBL] [Abstract][Full Text] [Related]
31. Application of photo-magnetic therapy for treatment of skin radiation damage in rats.
Simonova-Pushkar LI; Gertman VZ; Bilogurova LV
Probl Radiac Med Radiobiol; 2014 Sep; 19():458-70. PubMed ID: 25536583
[TBL] [Abstract][Full Text] [Related]
32. Exploitation of the Apoptosis-Primed State of MYCN-Amplified Neuroblastoma to Develop a Potent and Specific Targeted Therapy Combination.
Ham J; Costa C; Sano R; Lochmann TL; Sennott EM; Patel NU; Dastur A; Gomez-Caraballo M; Krytska K; Hata AN; Floros KV; Hughes MT; Jakubik CT; Heisey DA; Ferrell JT; Bristol ML; March RJ; Yates C; Hicks MA; Nakajima W; Gowda M; Windle BE; Dozmorov MG; Garnett MJ; McDermott U; Harada H; Taylor SM; Morgan IM; Benes CH; Engelman JA; Mossé YP; Faber AC
Cancer Cell; 2016 Feb; 29(2):159-72. PubMed ID: 26859456
[TBL] [Abstract][Full Text] [Related]
33. Injectable thermosensitive magnetic nanoemulsion hydrogel for multimodal-imaging-guided accurate thermoablative cancer therapy.
Wu H; Song L; Chen L; Huang Y; Wu Y; Zang F; An Y; Lyu H; Ma M; Chen J; Gu N; Zhang Y
Nanoscale; 2017 Nov; 9(42):16175-16182. PubMed ID: 28770920
[TBL] [Abstract][Full Text] [Related]
34. A Bimetallic Silver-Neodymium Theranostic Nanoparticle with Multimodal NIR/MRI/CT Imaging and Combined Chemo-photothermal Therapy.
Mishra SK; Kannan S
Inorg Chem; 2017 Oct; 56(19):12054-12066. PubMed ID: 28933536
[TBL] [Abstract][Full Text] [Related]
35. GRHL1 acts as tumor suppressor in neuroblastoma and is negatively regulated by MYCN and HDAC3.
Fabian J; Lodrini M; Oehme I; Schier MC; Thole TM; Hielscher T; Kopp-Schneider A; Opitz L; Capper D; von Deimling A; Wiegand I; Milde T; Mahlknecht U; Westermann F; Popanda O; Roels F; Hero B; Berthold F; Fischer M; Kulozik AE; Witt O; Deubzer HE
Cancer Res; 2014 May; 74(9):2604-16. PubMed ID: 24419085
[TBL] [Abstract][Full Text] [Related]
36. The long non-coding RNA MYCNOS-01 regulates MYCN protein levels and affects growth of MYCN-amplified rhabdomyosarcoma and neuroblastoma cells.
O'Brien EM; Selfe JL; Martins AS; Walters ZS; Shipley JM
BMC Cancer; 2018 Feb; 18(1):217. PubMed ID: 29466962
[TBL] [Abstract][Full Text] [Related]
37. Changes in MYCN expression in human neuroblastoma cell lines following cisplatin treatment may not be related to MYCN copy numbers.
Prochazka P; Hrabeta J; Vicha A; Cipro S; Stejskalova E; Musil Z; Vodicka P; Eckschlager T
Oncol Rep; 2013 Jun; 29(6):2415-21. PubMed ID: 23563570
[TBL] [Abstract][Full Text] [Related]
38. p19-INK4d inhibits neuroblastoma cell growth, induces differentiation and is hypermethylated and downregulated in MYCN-amplified neuroblastomas.
Dreidax D; Bannert S; Henrich KO; Schröder C; Bender S; Oakes CC; Lindner S; Schulte JH; Duffy D; Schwarzl T; Saadati M; Ehemann V; Benner A; Pfister S; Fischer M; Westermann F
Hum Mol Genet; 2014 Dec; 23(25):6826-37. PubMed ID: 25104850
[TBL] [Abstract][Full Text] [Related]
39. MYCN silencing induces differentiation and apoptosis in human neuroblastoma cells.
Kang JH; Rychahou PG; Ishola TA; Qiao J; Evers BM; Chung DH
Biochem Biophys Res Commun; 2006 Dec; 351(1):192-7. PubMed ID: 17055458
[TBL] [Abstract][Full Text] [Related]
40. Tumor-Microenvironment-Activatable Nanoreactor Based on a Polyprodrug for Multimodal-Imaging-Medicated Enhanced Cancer Chemo/Phototherapy.
Shi X; Ma X; Ren E; Zhang Y; Jia D; Gao Y; Xue P; Kang Y; Liu G; Xu Z
ACS Appl Mater Interfaces; 2019 Oct; 11(43):40704-40715. PubMed ID: 31577408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
